Ranbaxy Wants Equal Trial Time In 'Bet The Company' MDL

By Brian Dowling (January 14, 2022, 1:05 PM EST) -- Ranbaxy Inc. is urging a Boston federal judge to give it equal time to defend itself in an upcoming "bet the company" trial with tens of billions of dollars potentially at stake on claims it manipulated the drug approval process to block competitors from making generic versions of three drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!